{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:45:20Z","timestamp":1761324320963,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 63-year-old man with recent diagnosis of high-risk prostate adenocarcinoma was referred to our Nuclear Medicine Department for <jats:sup>18<\/jats:sup>F-fluciclovine PET\/CT to rule out metastasis in the setting of elevated serum prostate-specific antigen levels. The patient had previous history of nodular melanoma of the right cheek treated 6 years back with surgery and adjuvant radiation. Surveillance <jats:sup>18<\/jats:sup>F-FDG PET\/CT for melanoma 1 month back had revealed enlarged FDG-avid mediastinal para-aortic lymph nodes, which on endoscopic biopsy had revealed melanoma metastasis. On current fluciclovine PET\/CT, the same enlarged para-aortic lymph nodes showed fluciclovine uptake, suggesting false-positive uptake.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003319","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T19:16:06Z","timestamp":1602184566000},"page":"e97-e99","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["18F-Fluciclovine\u2013Avid Mediastinal Lymph Node Metastasis of Cutaneous Malignant Melanoma"],"prefix":"10.1097","volume":"46","author":[{"given":"Ahmad","family":"Shariftabrizi","sequence":"first","affiliation":[{"name":"Iowa City Veterans Affairs Health Care System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravishankar","family":"Pillenahalli Maheshwarappa","sequence":"additional","affiliation":[{"name":"University of Iowa Hospitals and Clinics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Kahn","sequence":"additional","affiliation":[{"name":"Iowa City Veterans Affairs Health Care System"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Pollard","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fonc.2019.01438","article-title":"Diagnostic performance of PET\/CT using 18F-FACBC in prostate cancer: a meta-analysis","volume":"9","year":"2020","journal-title":"Front Oncol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ucl.2018.03.015","article-title":"Imaging of prostate cancer using fluciclovine","volume":"45","year":"2018","journal-title":"Urol Clin North Am"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2967\/jnumed.114.143628","article-title":"Anti\u20131-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"e614","DOI":"10.1097\/RLU.0000000000002670","article-title":"Uptake of 18F-fluciclovine in Paget disease","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2214\/AJR.19.21894","article-title":"Extraprostatic uptake of 18F-fluciclovine: differentiation of nonprostatic neoplasms from metastatic prostate cancer","volume":"214","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/RLU.0000000000001789","article-title":"Recurrent malignant melanoma detected on 18F-fluciclovine PET\/CT imaging for prostate cancer","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","first-page":"1164","article-title":"Think outside the box: tackling fluciclovine PET-CT with challenging extraprostatic findings","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/CMR.0000000000000181","article-title":"Prognostic significance of l-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma","volume":"25","year":"2015","journal-title":"Melanoma Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:04:51Z","timestamp":1750539891000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003319","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2020,10,8]]}}}